ES2072095T3 - Derivados de tiazolidinona y oxazolidinona, su preparacion y su uso como vasodilatadores. - Google Patents

Derivados de tiazolidinona y oxazolidinona, su preparacion y su uso como vasodilatadores.

Info

Publication number
ES2072095T3
ES2072095T3 ES92302674T ES92302674T ES2072095T3 ES 2072095 T3 ES2072095 T3 ES 2072095T3 ES 92302674 T ES92302674 T ES 92302674T ES 92302674 T ES92302674 T ES 92302674T ES 2072095 T3 ES2072095 T3 ES 2072095T3
Authority
ES
Spain
Prior art keywords
thiazolidinone
vasodilators
preparation
aralkyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92302674T
Other languages
English (en)
Inventor
Sadao C O Sankyo Comp Ishihara
Fujio C O Sankyo Company Saito
Takao C O Sankyo Comp Yoshioka
Hiroyuki C O Sankyo Comp Koike
Sigeki C O Sankyo Compa Miyake
Hiroshi C O Sankyo Comp Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2072095T3 publication Critical patent/ES2072095T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Indole Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE LA TIAZOLIDINONA Y OXAZOLIDINONA, SU PREPARACION Y SU USO COMO VASODILATADORES. SE PRESENTAN COMPUESTOS DE LA FORMULA: EN LA CUAL W REPRESENTA UN ATOMO DE AZUFRE O DE OXIGENO Y X REPRESENTA UN GRUPO DE LA FORMULA -N(R1), O W REPRESENTA UN GRUPO DE LA FORMULA -N(R1) DROGENO, ALQUIL, O ARALQUIL; R2 Y R3 SON CADA UNA DE ELLAS HIDROGENO, ALQUIL, ARALQUIL, ARIL O UN ETEROCICLICO AROMATICO; R4 ES HIDROGENO, ALQUIL O ARALQUIL; Y A ES ALQUILENO QUE ESTA OPCIONALMENTE SUBSTITUIDO POR CARBOXIDO, ASI MISMO SE PRESENTAN SUS SALES FARMACEUTICAMENTE ACEPTABLES Y LOS ESTERES DEL MISMO, LOS CUALES PRESENTAN UNA EVALUABLE ACTIVIDAD VASODILATADORA.
ES92302674T 1991-03-27 1992-03-27 Derivados de tiazolidinona y oxazolidinona, su preparacion y su uso como vasodilatadores. Expired - Lifetime ES2072095T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6308891 1991-03-27
JP10275191 1991-05-08
JP33030491 1991-12-13

Publications (1)

Publication Number Publication Date
ES2072095T3 true ES2072095T3 (es) 1995-07-01

Family

ID=27298042

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92302674T Expired - Lifetime ES2072095T3 (es) 1991-03-27 1992-03-27 Derivados de tiazolidinona y oxazolidinona, su preparacion y su uso como vasodilatadores.

Country Status (23)

Country Link
US (2) US5298516A (es)
EP (1) EP0506434B1 (es)
JP (1) JPH0780859B2 (es)
KR (1) KR0152097B1 (es)
CN (2) CN1031824C (es)
AT (1) ATE118770T1 (es)
AU (1) AU647599B2 (es)
CA (1) CA2064108C (es)
CZ (1) CZ282529B6 (es)
DE (1) DE69201451T2 (es)
DK (1) DK0506434T3 (es)
ES (1) ES2072095T3 (es)
FI (1) FI106260B (es)
HK (1) HK123595A (es)
HU (2) HU217969B (es)
IE (1) IE67383B1 (es)
IL (1) IL101395A (es)
IS (1) IS1746B (es)
NO (1) NO304311B1 (es)
NZ (1) NZ242154A (es)
PH (1) PH30493A (es)
RU (1) RU2055073C1 (es)
TW (1) TW226015B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
WO1994021248A1 (de) * 1993-03-15 1994-09-29 Byk Nederland Bv Verwendung von substituierten alkylnitraten zur behandlung des krankhaft erhöhten augeninnendruckes
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DK0798298T3 (da) * 1994-12-15 2001-10-22 Sankyo Co Thiazolidinon- eller oxazolidonderivater til behandling af angina pectoris eller sammensætninger indeholdende samme som aktiv bestanddel
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
PT812835E (pt) * 1995-03-02 2001-08-30 Sankyo Co Derivados opticamente activos de tiazolidinona
AU6016496A (en) * 1995-06-14 1997-01-15 Sankyo Company Limited Antianginal drug comprising nitroxy derivative as active ingredient
BE1010768A3 (nl) * 1996-11-26 1999-01-05 Dsm Nv Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan.
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
WO2002069967A1 (fr) * 2001-03-01 2002-09-12 Sankyo Company, Limited Compositions a absorption percutanee
EP2736890A4 (en) * 2011-07-28 2015-07-15 Promentis Pharm Inc Cysteine PRODRUGS
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
DK0393911T3 (da) * 1989-04-21 1994-10-03 Du Pont Fungicide oxazolidinoner

Also Published As

Publication number Publication date
JPH0780859B2 (ja) 1995-08-30
CN1066067A (zh) 1992-11-11
CN1031824C (zh) 1996-05-22
IL101395A (en) 1996-10-16
HU211969A9 (en) 1996-01-29
KR0152097B1 (ko) 1998-10-15
DE69201451T2 (de) 1995-10-12
NO921159L (no) 1992-09-28
FI106260B (fi) 2000-12-29
HU9201033D0 (en) 1992-06-29
EP0506434B1 (en) 1995-02-22
DE69201451D1 (de) 1995-03-30
HK123595A (en) 1995-08-04
CN1096265C (zh) 2002-12-18
CA2064108A1 (en) 1992-09-28
PH30493A (en) 1997-05-28
IE67383B1 (en) 1996-03-20
AU647599B2 (en) 1994-03-24
IE920966A1 (en) 1992-10-07
NO921159D0 (no) 1992-03-25
IS3828A (is) 1992-09-28
HU217969B (hu) 2000-05-28
EP0506434A1 (en) 1992-09-30
FI921340A (fi) 1992-09-28
CA2064108C (en) 2000-09-26
CN1113435A (zh) 1995-12-20
IL101395A0 (en) 1992-11-15
US5356918A (en) 1994-10-18
FI921340A0 (fi) 1992-03-26
ATE118770T1 (de) 1995-03-15
NO304311B1 (no) 1998-11-30
JPH05213910A (ja) 1993-08-24
HUT68242A (en) 1995-06-28
DK0506434T3 (da) 1995-07-24
CZ282529B6 (cs) 1997-08-13
NZ242154A (en) 1993-09-27
TW226015B (es) 1994-07-01
CZ91692A3 (en) 1993-01-13
RU2055073C1 (ru) 1996-02-27
KR920018036A (ko) 1992-10-21
IS1746B (is) 2000-07-11
AU1312292A (en) 1992-10-01
US5298516A (en) 1994-03-29

Similar Documents

Publication Publication Date Title
FI93450B (fi) Menetelmä terapeuttisesti käyttökelpoisten 10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/undek-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
FR2689130B1 (fr) Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
ES2072095T3 (es) Derivados de tiazolidinona y oxazolidinona, su preparacion y su uso como vasodilatadores.
ATE145906T1 (de) Benzamid-derivate
DE3750411D1 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Präparate.
PT916651E (pt) DERIVADOS DE áCIDO FENILALQUILCARBOXILICO
IE822310L (en) Triazoloquinazolone derivatives
ATE2219T1 (de) Phenyl-piperazin-derivate, ihre herstellung und sie enthaltende anti-agressive heilmittel.
FI941517A0 (fi) Bentsonaftyridiinin-1,8 johdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
ATE49761T1 (de) 8-thiotetrahydrochinoleinderivate und deren salze.
FI871253A (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506434

Country of ref document: ES